Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPRODRIGUES, Priscila AparecidaZANINOTTO, Ana LuizaNEVILLE, Luri SantanaHAYASHI, Cintya YukieBRUNONI, Andre R.TEIXEIRA, Manoel JacobsenPAIVA, Wellingson Silva2019-11-062019-11-062019NEUROPSYCHIATRIC DISEASE AND TREATMENT, v.15, p.2743-2761, 2019https://observatorio.fm.usp.br/handle/OPI/33940Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulatory options with the potential to improve mood changes, we highlight repetitive transcranial magnetic stimulation (rTMS). rTMS is a viable therapeutical option for neuropsychiatric dysfunctions of high prevalence and is important for the understanding of pathological and neuropsychological adaptation processes. Even with this potential, and high relevance of intervention, we observe the scarcity of literature that covers this subject. The objective of this study was to carry out a survey of the current literature, using scientific databases for the last five years. We found 32 studies reporting the effects of rTMS on anxiety, 7 on anxiety disorders and 25 on anxiety symptoms as comorbidities of neurological or psychiatric disorders. This survey suggests the need for further studies using TMS for anxiety in order to seek strategies that minimize these anxiety effects on the quality of life of the victims of this disorder.engopenAccesstranscranial magnetic stimulationanxiety disordersreviewtreatmentdorsolateral prefrontal cortexperipheral nervous-systemsham-controlled-trialdouble-blindmajor depressionchronic tinnituspanic disordermotor cortexbrainrtmsarticleCopyright DOVE MEDICAL PRESS LTD10.2147/NDT.S201407Clinical NeurologyPsychiatry1178-2021